Riverwood Capital

As the new financial year kicks off, the Indian equity market is bracing for a significant supply-side event. According to data compiled by IPO Central for the month of April, six major companies are set to see their mandatory anchor investor lock-in periods expire. This will collectively release over 13 crore shares into the free-float […]

The Indian primary market witnessed the strong pipeline visibility in Fy26 and as we are going to enter in FY27, we can expect the same momentum. After a relatively strong March in terms of IPO (not in terms of returns 😁), April could also show strong market pace. Market sentiments remained weak throughout March, and

Industrial manufacturing players are now gaining prominence in the upcoming IPO pipeline. In this context, Pioneer Fil-Med has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI). Pioneer Fil-Med IPO is aiming to raise ~INR 500 crore through a combination of fresh issue and offer for sale. Nuvama

PropShare Celestia SM REIT IPO description –PropShare Celestia is the third SM REIT scheme launched by Property Share Investment Trust (PSIT), representing a strategic entry into Ahmedabad’s prime Nehru Nagar (SBD) micro-market. The scheme involves the acquisition of 2,07,838 sq. ft. spread across seven floors of Stratum @ Venus Grounds, a landmark Grade A+ mixed-use commercial

Innovassynth Technologies Rights Issue dates is not finalized. Innovassynth Technologies (India) is a specialty chemicals company operating as a Custom Development and Manufacturing Organisation (CDMO), catering to global clients across life sciences and industrial chemistry segments. The company’s core focus lies in niche, high-value chemistries such as nucleosides, organometallics, metallocenes, and polymer catalysts, which find